1.
N-acetyltransferase 2 polymorphism in Parkinson's disease. The Rotterdam study
2.
N-acetyltransferase-2 polymorphism in Parkinson's disease: the Rotterdam study
Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study
Interaction between hypertension, apoE, and cerebral white matter lesions.
Atherosclerosis, apolipoprotein E and the prevalence of dementia and Alzheimer's disease in a population-based study: the Rotterdam Study